WO2023089459 - SYSTEMS AND METHODS FOR VITREOUS DISEASE SEVERITY MEASUREMENT
National phase entry:
Publication Number
WO/2023/089459
Publication Date
25.05.2023
International Application No.
PCT/IB2022/060853
International Filing Date
10.11.2022
Title **
[English]
SYSTEMS AND METHODS FOR VITREOUS DISEASE SEVERITY MEASUREMENT
[French]
SYSTÈMES ET PROCÉDÉS DE MESURE DE LA GRAVITÉ D'UNE MALADIE VITREUSE
Applicants **
ALCON INC.
Inventors
HALLEN, Paul R.
Priority Data
63/281,286
19.11.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
* |
| Recordal of a Change of the Applicant's Name/Address | * |
| Type of Assignment | * |
| Applicant's Legal Status | * |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under | * |
| Patent Delivery | * |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2105 | |
| EPO | Filing, Examination, Granting | 8919 | |
| Japan | Filing, Examination, Granting | 2279 | |
| South Korea | Filing, Examination, Granting | 2324 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,367
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Certain aspects presented herein provide systems and methods utilizing one or more machine learning models in determining a severity of vitreous disease, and in particular, vitreous opacities. Such machine learning models are trained based on historical patient data to determine the severity of vitreous opacities afflicting a current patient. The severity determination may thereafter be utilized to inform treatment decisions for the current patient, including patient suitability for certain types of treatment.[French]
Certains aspects de la présente invention concernent des systèmes et des procédés utilisant un ou plusieurs modèles d'apprentissage machine pour déterminer la gravité d'une maladie vitreuse, et en particulier, des agents opacifiants vitreux. De tels modèles d'apprentissage machine sont entraînés sur la base de données historiques de patient pour déterminer la gravité d'agents opacifiants vitreux affectant un patient actuel. La détermination de la gravité peut ensuite être utilisée pour informer des décisions de traitement pour le patient actuel, y compris le caractère approprié du patient pour certains types de traitement.